18/05/2019 21:59:17

Ambu A/S: Cook Medical and Ambu announce collaboration to address endoscope-related infections

Cook Medical and Ambu A/S have agreed on terms to enter into a partnership under which Cook will distribute Ambu’s single-use, disposable duodenoscope in the U.S., following FDA clearance. The scope is currently being developed by Ambu to help address infections caused by cross-contamination*. Since 2015, U.S. regulatory authorities have increased their focus on endoscope cross-contamination, particularly reusable endoscopes for gastrointestinal use.

The use of reusable endoscopes can pose a contamination risk to patients because the devices are difficult to reprocess between uses. Alternatively, single-use scopes could have a significant impact on device-related infections and improve hospital workflows because they do not require cleaning or repair.

Our mission is to improve patient care and we were looking for a solution to reduce the risk of infections associated with the use of reusable endoscopes,” said Barry Slowey, Vice President of Cook Medical’s Endoscopy business. “Our collaboration with Ambu is based on a shared goal to enhance patient safety.

"This is a significant milestone towards our vision of a single-use ERCP solution,” said Juan Jose Gonzalez, CEO of Ambu. “Together with Cook Medical we plan to bring single-use endoscopes to patients undergoing ERCP procedures, to reduce the risk of serious cross-contaminations."

No further details about the agreement will be disclosed at this time, but the agreement is not expected to have any impact on the outlook for Ambu concerning growth, earnings or free cash flows towards September 2020 as put forth in connection to the earnings relase for H1 on May 1 2019.

*Ambu is currently pursuing regulatory clearance from the U.S. FDA for its single-use duodenoscope. These products are currently not available for sale in the U.S. Expected release for sale is before end of September 2020.

Media contact, Cook Medical

Christa Curtis

Global Director, Corporate Marketing and Communications, Cook Medical

Christa.Curtis@CookMedical.com

812.339.2235 ext. 10-5352 (office)

812.929.0208 (mobile)

Media contact, Ambu A/S

Morten Huse Eikrem-Jeppesen

PressConnect

morten@pressconnect.dk

+45 5385 0770 (mobile)

Attachment

logo.png

Related content
17 Jun - 
Ambu A/S: Review of the Big Five 2020 Strategy
10 May - 
Ambu A/S: Ambu appoints new CEO
09 May - 
Ambu A/S: Updated Articles of Association May 2019
Related debate
01:38 - 
Var det virkelig kun det. Har ikke den store betydning
00:23 - 
Skal shorter ud nu?
00:17 - 
Så kom der da ro på, nu ved vi hvad vi kan forvente, be..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
11 Jun
AMBU-B
Vi kom da næsten over 110 🙂 Mon ikke stigningen fortsætter de næste stykke tid 🤞😊
7
14 Jun
AMBU-B
Aktier bliver prissat efter forventninger.. Ambu er spået til at blive en af verdens største medico..
5
14 Jun
AMBU-B
Omkring 98.. Den har intet positivt momentum og laver præcis samme nummer som pandora det sidste par..
4
12 Jun
AMBU-B
Hvis man tror at noget er 100 % sikkert inden for aktie handel så skal man finde noget andet at besk..
4
11 Jun
AMBU-B
Jeg synnes det er fint med disse artikler, hvor vi får bevægelsesgrundladet for de massive shorts de..
4
11 Jun
AMBU-B
Artikel plantet af shortere. Jeg har skrevet til Børsen om hvad AMBU selv siger om den påstand. De h..
4
17 Jun
AMBU-B
Jeg tror den vil stige. Mange havde forventet noget der var langt værre.
3
14 Jun
AMBU-B
Ambu børsværdi er 3 mia mere end Pandora Ambu omsætter for 785mio i kvartalet og Pandora 4800mio i k..
3
12 Jun
AMBU-B
"konkurance"(!) - lad mig gætte med i gættekonkurrencen: du er ikke faglærer i faget retskrivning...
3
12 Jun
AMBU-B
Den burde stige, men det ser ikke lige ud som sådan.   P Sar er startet under candelstick.  MA9 ser ..
3

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Issue of Equity
2
AS VALMIERAS STIKLA ŠĶIEDRA files for legal protection proceedings to ensure sustainable continuation of Group-level operations
3
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Livent Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
4
MODERN HEALTHCARE RECOGNIZES NEVADA LEADER AS ONE OF THE NATION’S 50 MOST INFLUENTIAL U.S. CLINICAL EXECUTIVES
5
Ziyen Inc. Engages Leading FINRA regulated Digital Bank, Prime Trust LLC

Related stock quotes

Ambu A/S 104,55 1.4% Stock price increasing

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
18 June 2019 04:58:17
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB2 - 2019-06-18 05:58:17 - 2019-06-18 04:58:17 - 1000 - Website: OKAY